ADMA BIOLOGICS, INC. Cash Equivalents, at Carrying Value
ADMA BIOLOGICS, INC. (ADMA) had Cash Equivalents, at Carrying Value of $45.30 million as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Balance Sheet › Assets › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2024-05-09
- 2024-03-31: Cash Equivalents, at Carrying Value $45.30M.
- 2023-12-31: Cash Equivalents, at Carrying Value $51.40M.
- 2023-09-30: Cash Equivalents, at Carrying Value $74.20M.
- 2023-06-30: Cash Equivalents, at Carrying Value $62.50M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2024-03-31 | $45.30M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $51.40M 10-K · filed 2024-02-28 |
| 2023-09-30 | $74.20M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $62.50M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $69.20M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $86.50M 10-K · filed 2023-03-23 |
| 2022-09-30 | $34.90M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $52.40M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $69.50M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $51.10M 10-K · filed 2022-03-24 |
| 2021-09-30 | $34.40M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $42.40M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $62.00M 10-Q · filed 2021-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |